2BB score and signals
Marker Therapeutics Inc’s current 2BB score is 18 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 19 | Very Weak |
| Quality | 20 | Weak |
| Risk | 49 | Moderate |
Company facts
| Headquarters | Houston, Texas, United States |
| Founded | 1992 |
| Employees | 5 |
| 52-week range | $0.81 – $2.46 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-11 | — | -0.2754 | — | $729,636.00 |
| 2026-08-12 | — | -0.221 | — | $695,640.00 |
| 2026-05-15 | -0.16 | -0.187 | $0.00 | $695,640.00 |
| 2026-03-18 | -0.09 | -0.2006 | $1.10M | $695,640.00 |
Related companies
